SU477580A3 - The method of cleaning serum - Google Patents

The method of cleaning serum

Info

Publication number
SU477580A3
SU477580A3 SU1186878A SU1186878A SU477580A3 SU 477580 A3 SU477580 A3 SU 477580A3 SU 1186878 A SU1186878 A SU 1186878A SU 1186878 A SU1186878 A SU 1186878A SU 477580 A3 SU477580 A3 SU 477580A3
Authority
SU
USSR - Soviet Union
Prior art keywords
serum
rpm
hours
cleaning
silicic acid
Prior art date
Application number
SU1186878A
Other languages
Russian (ru)
Inventor
Штефан Вольфганг
Original Assignee
Биотест-Серум Институт Гмбх (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1966B0089704 external-priority patent/DE1617335B2/en
Application filed by Биотест-Серум Институт Гмбх (Фирма) filed Critical Биотест-Серум Институт Гмбх (Фирма)
Application granted granted Critical
Publication of SU477580A3 publication Critical patent/SU477580A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods

Description

гируют, облучают ультрафиолетовыми лучами и стерильно фильтруют. После четырехнедельного хранени  при 5°С отфильтровывают от случайно образовавшегос  незначительного осадка.guarded, irradiated with ultraviolet rays and sterile filtered. After four weeks of storage at 5 ° C, a slight precipitate is formed by accident.

Пример 4. 1 л человеческой АСД-сыворотки устанавливают на 5,5% нротеина н при значении рН 6,5 хорошо смешивают с коллоидной кремниевой кислотой 4 ч при комнатной температуре и затем 4 ч нагревают при 45°С. После охлаждени  центрифугируют 30 мин при 5000 об/мин, облучают ультрафиолетовыми лучами и стерильно фильтруют. После четырехчасового хранеии  при 5°С отфильтровывают от случайно образовавшегос  осадка.Example 4. One liter of human ASD serum is adjusted to 5.5% nrotein n at pH 6.5 and is well mixed with colloidal silicic acid for 4 hours at room temperature and then heated for 4 hours at 45 ° C. After cooling, the mixture is centrifuged for 30 minutes at 5000 rpm, irradiated with ultraviolet rays, and sterile filtered. After four hours of storage at 5 ° C, the precipitate formed at random is filtered.

Пример 5. 1 л цитратной плазмы (протеин: 5,0%, рН 7,5) размешивают с 20 г аэрозила 380 при 45°С в течение 4 ч. Центрифугируют в течение 20 мин нри 5000 об/мин н сливают верхнюю фазу.Example 5. 1 l citrate plasma (protein: 5.0%, pH 7.5) is stirred with 20 g of aerosil 380 at 45 ° C for 4 hours. Centrifuged for 20 minutes at 5000 rpm and the upper phase is drained.

Пример 6. 1 л плазмы (нротеин: 7,0, рН 7,6) размешивают с 20 г аэрозила 380 в течение 4 ч при 45°С. Центрифугируют в течение 20 мин при 5000 об/мин, сливают верхнюю фазу и стерильно фильтруют через фильтр типа Зейтц-EKS-l. Затем облучают адсорбированную сыворотку ультрафиолетовыми лучами .Example 6. 1 l of plasma (nrotein: 7.0, pH 7.6) is stirred with 20 g of aerosil 380 for 4 hours at 45 ° C. The mixture is centrifuged for 20 minutes at 5000 rpm, the upper phase is drained and sterile filtered through a Seitz-EKS-1 filter. Then the adsorbed serum is irradiated with ultraviolet rays.

Пример 7. 1 л человеческой сыворотки при значении рН 7 хорошо размешивают с 20 г стерилизованной гор чим воздухом коллоидной кремниевой кислоты в течение 3 ч при 30°С и после охлаждени  центрифугируют в течение 30 .мин при 5000 об/мин, облучают ультрафиолетовыми лучами и фильтруют через фильтр из подход ш,его материала и с соответствуюш,им размером нор. По истечении четырехнедельного хранени  при 5°С отфильтровывают случайно образовавшийс  малый осадок.Example 7. 1 l of human serum at pH 7 was well stirred with 20 g of colloidal silicic acid sterilized with hot air for 3 hours at 30 ° C and, after cooling, centrifuged for 30 minutes at 5000 rpm, irradiated with ultraviolet rays and filter through the filter from the approach of w, its material and with the corresponding, the size of holes. After four weeks of storage at 5 ° C, a small precipitate that is formed is filtered by chance.

Пример 8. 1 л человеческой сыворотки при значении рН 7 хорошо размешивают с 20 г стерилизированной гор чим воздухом коллоидной кремниевой кислоты в течение 4 чExample 8. 1 l of human serum at pH 7 is well stirred with 20 g of hot air sterilized colloidal silicic acid for 4 hours

при 15°С н после охлаждени  центрифугируют в течение 30 мин при 6000 об/мин, облучают ультрафиолетовыми лучами н фильтруют через фильтровые слои, содержащие асбест, непроницаемый дл  бактерий, и с под.х:од ш,им размером пор. По истечении четырехнедельного хранени  при 5°С отфильтровывают случайно образовавшийс  малый осадок.after cooling at 15 ° C, centrifuged for 30 minutes at 6000 rpm, irradiated with ultraviolet rays, filtered through filter layers containing asbestos impermeable to bacteria, and with water: one, pore size. After four weeks of storage at 5 ° C, a small precipitate that is formed is filtered by chance.

Пример 9. Способ, приведенный в примере 8, повтор етс  при 5°С, причем размешнвание продолжают б ч.Example 9. The method described in Example 8 is repeated at 5 ° C, with stirring being continued bh.

Употребл ема  коллоидна  кремниева  кислота имеет следуюш,ие свойства;Colloidal silicic acid used has the following properties;

Насыпной вес 20-125 (предпочтительно 40-60) ,г/л.Bulk weight 20-125 (preferably 40-60), g / l.

Величина частиц 3-60 (предпочтительно ) ммк.The size of the particles 3-60 (preferably) MMK.

Удельна  поверхность 100-500 (нредпочтительно 340-420) ..The specific surface area is 100-500 (preferably 340-420) ..

Коллоидную кремниевую кислоту смешивают с сывороткой посредством врандепи  адсорбционных сосудов со скоростью (предпочтительно 30) об/мин; посредством размешивани  при 10-50 (предпочтительно 30) об/мин.Colloidal silicic acid is mixed with serum by means of vrandepi adsorption vessels with a speed (preferably 30) rpm; by stirring at 10-50 (preferably 30) rpm.

Подход ш;ими вставными фильтрами  вл ютс , нанример, целлюлозно-асбестовые фильтры с размерами пор 0,8-8 (предпочтительно 0,9-1,2) мк при фильтрационном давлении от 0,5 до 4 атмосфер. Кроме того, примен ют . мембранные фильтры е размерами пор от 0,05 до 0,5 (предпочтительно 0,2) мк при фильтрационном давлении 1-10 (предпочтительно 5) атмосфер.The approach is встав; these plug-in filters are, for example, cellulose-asbestos filters with a pore size of 0.8-8 (preferably 0.9-1.2) microns with a filtration pressure of from 0.5 to 4 atmospheres. In addition, apply. membrane filters with pore size from 0.05 to 0.5 (preferably 0.2) micron with a filtration pressure of 1-10 (preferably 5) atmospheres.

Предмет изобретени Subject invention

Способ очистки сыворотки путем обработки сорбентом, фильтрации и ультрафиолетового облучени , отличаюшийс  тем, что, с целью повышени  чистоты препарата, сыворотку соедин ют с коллоидной кремниевой кислотой в соотношении 250-500 мг на 1 г белка нри рН 6,5-8,0.The method of cleaning the serum by sorbent treatment, filtration and ultraviolet irradiation, characterized in that, in order to increase the purity of the preparation, the serum is combined with colloidal silicic acid in a ratio of 250-500 mg per 1 g of protein at pH 6.5-8.0.

SU1186878A 1966-04-06 1967-09-29 The method of cleaning serum SU477580A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEB0086560 1966-04-06
DE1966B0089704 DE1617335B2 (en) 1966-11-05 1966-11-05 PROCESS FOR MANUFACTURING LIPOPROTEIN-FREE, STABLE AND STERILE SERUM
DEB0091011 1967-02-02

Publications (1)

Publication Number Publication Date
SU477580A3 true SU477580A3 (en) 1975-07-15

Family

ID=27209344

Family Applications (1)

Application Number Title Priority Date Filing Date
SU1186878A SU477580A3 (en) 1966-04-06 1967-09-29 The method of cleaning serum

Country Status (8)

Country Link
US (1) US3686395A (en)
AT (1) AT270868B (en)
BE (1) BE696020A (en)
FR (1) FR7395M (en)
GB (1) GB1115849A (en)
NL (1) NL6702923A (en)
SE (1) SE328089B (en)
SU (1) SU477580A3 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822095A (en) * 1972-08-14 1974-07-02 Block Engineering System for differentiating particles
DE2364317C3 (en) * 1973-12-22 1979-10-11 Behringwerke Ag, 3550 Marburg Procedure for the isolation of choleragen
DK139056B (en) * 1976-04-06 1978-12-11 Nordisk Insulinlab Method for recovering immunoglobulin suitable for intravenous administration.
US4164495A (en) * 1976-04-06 1979-08-14 Nordisk Insulinlaboratorium Method of recovering immunoglobulin using a polyol and an alkanoic acid
US4136094A (en) * 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin
JPS5446813A (en) * 1977-09-22 1979-04-13 Toyo Soda Mfg Co Ltd Separation of plasmaprotein
DE2837168A1 (en) * 1978-08-25 1980-03-06 Blutspendedienst Dt Rote Kreuz METHOD FOR PRODUCING AN IMMUNAL GLOBULIN SOLUTION SUITABLE FOR INTRAVENOUS APPLICATION
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
US4378346A (en) * 1979-08-15 1983-03-29 Tankersley Donald L Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
US4251510A (en) * 1979-08-15 1981-02-17 Cutter Laboratories, Inc. Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
US4473647A (en) * 1981-02-27 1984-09-25 Amf Inc. Tissue culture medium
US4480029A (en) * 1981-04-27 1984-10-30 Baxter Travenol Laboratories, Inc. Biological indicators and their use
US4511473A (en) * 1982-02-09 1985-04-16 Amf Incorporated Fibrous media containing millimicron-sized particulates
US4578150A (en) * 1982-07-23 1986-03-25 Amf Inc. Fibrous media containing millimicron-sized particulates
DE3247150A1 (en) * 1982-12-21 1984-06-28 Biotest-Serum-Institut Gmbh, 6000 Frankfurt CLOTHING ACTIVE PLASMA PROTEIN REDUCTION, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR TREATING DISORDERS OF THE HAEMOSTASE SYSTEM
AU2492084A (en) * 1983-01-26 1984-08-15 Amf Inc. Tissue culture medium
US4533634A (en) * 1983-01-26 1985-08-06 Amf Inc. Tissue culture medium
US4639513A (en) * 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
DE3483751D1 (en) * 1983-05-02 1991-01-31 Diamond Scient Co PHOTOCHEMICAL DISABLING TREATMENT OF FULL BLOOD OR BLOOD COMPONENTS.
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
DE3330770A1 (en) * 1983-08-26 1985-03-14 Behringwerke Ag, 3550 Marburg METHOD FOR PASTEURIZING HUMAN PLASMA
US5418130A (en) * 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
NL9401535A (en) * 1994-09-21 1996-05-01 Stichting Scheikundig Onderzoe Serum-prepared protein mixture for use as a component in media for in vitro culture of animal cells.
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2469193A (en) * 1942-02-09 1949-05-03 Research Corp Protein fractionation
US3284434A (en) * 1960-08-29 1966-11-08 Univ Kansas State Protein isolation and preparations

Also Published As

Publication number Publication date
GB1115849A (en) 1968-05-29
NL6702923A (en) 1967-10-09
BE696020A (en) 1967-09-25
FR7395M (en) 1969-11-03
AT270868B (en) 1969-05-12
SE328089B (en) 1970-09-07
US3686395A (en) 1972-08-22

Similar Documents

Publication Publication Date Title
SU477580A3 (en) The method of cleaning serum
Guo et al. Hollow mesoporous carbon spheres—an excellent bilirubin adsorbent
US3470067A (en) Concentration and purification of viruses from particulate magnetic iron oxide-virus complexes
CA2796409A1 (en) Process for preparing an immunoglobulin composition
US3608071A (en) Manufacturing adsorbed vaccines
Sabin Experiments on the purification and concentration of the virus of poliomyelitis
JPH04169539A (en) Preventive and therapeutic agent for alimetary disease and production thereof
US5696236A (en) Method for the removal of viruses from protein solutions
US10357512B2 (en) Method for preparing universal plasma
ATE25690T1 (en) PLASMA PROTEIN SOLUTION WITH ACTIVE COAGAGATION, PROCESS FOR ITS PREPARATION AND ITS USE IN THE TREATMENT OF DISORDERS OF THE HEMOSTASIS SYSTEM.
Humphries Enzymic activity of bacteriophage-culture lysates: I. A capsule lysin active against Klebsiella pneumoniae type A
Bronfenbrenner STUDIES ON THE BACTERIOPHAGE OF D'HERELLE: VII. On the Particulate Nature of Bacteriophage.
US3547779A (en) Process for producing purified concentrated influenza virus
KR101164122B1 (en) Device for Manufacturing Therapeutic Immunoglobulin Preparation and Manufacturing Methods Using Thereof
Tamauchi et al. Enhancement of immunogenicity by incorporation of lipid A into liposomal model membranes and its application to membrane-associated antigens
Alexeyev et al. Impaired neutrophil function in the cutaneous form of anthrax
US3840458A (en) Process and apparatus for obtaining therapeutically active substances from animal tissue
CN107098966B (en) Immunoglobulin and preparation method thereof
US4843065A (en) Method of producing products for use in the treatment of bacterial and/or virus infections
Hunter et al. Response of mice to rabbit Fab′ 2 and Fab′: Thymus independence of IgM response and thymus dependence of IgG response
Bauer et al. Ultrafiltration of the virus of equine encephalomyelitis
McClung On the staining of yeast spores
JPS606660B2 (en) Method for manufacturing sterile artificial organs
CN107236038B (en) Method for improving protein clarity by microcrystalline cellulose, and product and application thereof
JPH06277673A (en) Silica containing apatite hydroxide bactericide and bactericidal treatment process